Can-Fite BioPharma Ltd. Interest Expense Nonoperating
Can-Fite BioPharma Ltd. (CANF) reported Interest Expense Nonoperating of $284.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-03-26
| Period end | Interest Expense Nonoperating 12 month | Interest Expense Nonoperating 12 month as first filed |
|---|---|---|
| 2025-12-31 | $284.00K 20-F · filed 2026-03-26 | |
| 2024-12-31 | $291.00K 20-F · filed 2026-03-26 | -$291.00K 20-F · filed 2025-04-14 |
| 2023-12-31 | $506.00K 20-F · filed 2026-03-26 | -$506.00K 20-F · filed 2025-04-14 |
| 2022-12-31 | -$222.00K 20-F · filed 2025-04-14 |